Design of Aminopeptidase N Inhibitors as Anti-cancer Agents

被引:87
|
作者
Amin, Sk Abdul [1 ]
Adhikari, Nilanjan [1 ]
Jha, Tarun [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Div Med & Pharmaceut Chem, Nat Sci Lab, POB 17020, Kolkata 700032, W Bengal, India
关键词
HEPATOCELLULAR-CARCINOMA CELLS; STREPTOMYCES-AZUREUS MH663-2F6; LEUCINE UREIDO DERIVATIVES; 1ST HIGHLY POTENT; MATRIX-METALLOPROTEINASE; CLINICAL-SIGNIFICANCE; SELECTIVE INHIBITORS; ACID-DERIVATIVES; PYRROLIDINE DERIVATIVES; BIOLOGICAL EVALUATION;
D O I
10.1021/acs.jmedchem.7b00782
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aminopeptidase N (APN) is an important metalloenzyme. It regulates multivariate cellular functions by different mechanisms such as enzymatic cleavage of peptides. This may play a role in endocytosis and regulate signal transduction. APN, a member of the MI zinc metallopeptidase family, plays crucial roles in a variety of functions such as migration and invasion, and angiogenesis and metastasis of tumor cells. Therefore, APN inhibitors may be useful for the treatment of cancer. In this Perspective, structure activity relationships of APN inhibitors are discussed to get an idea of possible lead candidates. APN inhibitors should possess an aryl hydrophobic function along with a zinc binding group attached to the hydrophobic group(s) to achieve high potency. This and other design aspects of APN inhibitors are discussed in this Perspective.
引用
收藏
页码:6468 / 6490
页数:23
相关论文
共 50 条
  • [31] Immunoconjugates as anti-cancer agents
    Pauptit, R
    Weston, S
    Rowsell, S
    Derbyshire, D
    Tucker, A
    STRUCTURE-BASED DRUG DESIGN: EXPERIMENTAL AND COMPUTATIONAL APPROACHES, 1998, 352 : 125 - 139
  • [32] Retinoids as anti-cancer agents
    Nagpal, S
    Chandraratna, RAS
    CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (03) : 295 - 316
  • [33] Anti-cancer agents - Preface
    Seymour, LK
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (25)
  • [34] Anti-cancer agents - Preface
    Niculescu-Duvaz, I
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (27)
  • [35] Indolocarbazoles as anti-cancer agents
    Prudhomme, M
    CURRENT PHARMACEUTICAL DESIGN, 1997, 3 (03) : 265 - 290
  • [36] Anti-cancer agents and endothelium
    Pacholczak, Renata
    Dropinski, Jerzy
    Walocha, Jerzy
    Musial, Jacek
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (05): : 249 - 256
  • [37] Anti-cancer agents - Preface
    Kozikowski, AP
    Baraldi, PG
    CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (17) : U2 - U3
  • [38] Anti-cancer agents - Preface
    Kozikowski, AP
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (12)
  • [39] Anti-cancer agents - Preface
    Capranico, G
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (22)
  • [40] Synthesis of anti-cancer agents
    Redda, Kinfe
    Gangapuram, Madhavi
    CANCER RESEARCH, 2009, 69